Wilson Sonsini Goodrich & Rosati advised BioSapien on the transaction. BioSapien, an Abu Dhabi-based biotech startup focused on drug delivery for localized cancer treatment, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Motif Neurotech on the transaction. Neurotechnology company, Motif Neurotech announced it raised $18.75 million in oversubscribed Series A financing round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
You must be a Standard 1 Year member to access this content.
